cholestyramine resin has been researched along with Lyme Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derham, A; Monro, JA; Puri, BK | 1 |
| Hakkarainen-Smith, JS; Monro, JA; Puri, BK | 1 |
| Hassler, D | 1 |
3 other study(ies) available for cholestyramine resin and Lyme Disease
| Article | Year |
|---|---|
Prevention of Infection in Adults Receiving Intravenous Antibiotic Treatment via Indwelling Central Venous Access Devices.
Topics: Academic Medical Centers; Administration, Oral; Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Cholestyramine Resin; Clostridium Infections; Databases, Factual; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lyme Disease; Male; Middle Aged; Retrospective Studies; Sampling Studies; Treatment Outcome; United Kingdom; Young Adult | 2019 |
The potential use of cholestyramine to reduce the risk of developing Clostridium difficile-associated diarrhoea in patients receiving long-term intravenous ceftriaxone.
Topics: Bacterial Proteins; Bacterial Toxins; Ceftriaxone; Cholestyramine Resin; Cohort Studies; Diarrhea; Enterotoxins; Humans; Lyme Disease; Models, Biological; Pilot Projects | 2015 |
[What is to be made of the therapy of borreliosis with cholestyramine and pioglitazone?].
Topics: Anti-Bacterial Agents; Cholestyramine Resin; Chronic Disease; Humans; Lyme Disease; Neurotoxins; Pioglitazone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2003 |